skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Female remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

Warneke, V.S. ; Behrens, H.-M. ; Böger, C. ; Becker, T. ; Lordick, F. ; Ebert, M.P.A. ; Röcken, C.

Annals of oncology, 2013-03, Vol.24 (3), p.725-733 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Moehler, M ; Maderer, A ; Schimanski, C ; Kanzler, S ; Denzer, U ; Kolligs, F.T ; Ebert, M.P ; Distelrath, A ; Geissler, M ; Trojan, J ; Schütz, M ; Berie, L ; Sauvigny, C ; Lammert, F ; Lohse, A ; Dollinger, M.M ; Lindig, U ; Duerr, E.M ; Lubomierski, N ; Zimmermann, S ; Wachtlin, D ; Kaiser, A.-K ; Schadmand-Fischer, S ; Galle, P.R ; Woerns, M

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3125-3135 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice
ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice

Maurer, M. ; Staubach, P. ; Raap, U. ; Richter-Huhn, G. ; Baier-Ebert, M. ; Chapman-Rothe, N.

British journal of dermatology (1951), 2016-04, Vol.174 (4), p.892-894 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome

Flanagan, L. ; Schmid, J. ; Ebert, M. ; Soucek, P. ; Kunicka, T. ; Liska, V. ; Bruha, J. ; Neary, P. ; Dezeeuw, N. ; Tommasino, M. ; Jenab, M. ; Prehn, J. H. M. ; Hughes, D. J.

European journal of clinical microbiology & infectious diseases, 2014-08, Vol.33 (8), p.1381-1390 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
5
Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis

WARNEKE, V. S ; BEHRENS, H.-M ; HAAG, J ; KRÜGER, S ; SIMON, E ; MATHIAK, M ; EBERT, M. P. A ; RÖCKEN, C

British journal of cancer, 2013-10, Vol.109 (8), p.2217-2227 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Schultheis, B ; Reuter, D ; Ebert, M P ; Siveke, J ; Kerkhoff, A ; Berdel, W E ; Hofheinz, R ; Behringer, D M ; Schmidt, W E ; Goker, E ; De Dosso, S ; Kneba, M ; Yalcin, S ; Overkamp, F ; Schlegel, F ; Dommach, M ; Rohrberg, R ; Steinmetz, T ; Bulitta, M ; Strumberg, D

Annals of oncology, 2017-10, Vol.28 (10), p.2429 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
7
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer

HEINEMANN, V ; EBERT, M. P ; LAUBENDER, R. P ; BEVAN, P ; MALA, C ; BOECK, S

British journal of cancer, 2013-03, Vol.108 (4), p.766-770 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells
WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells

Yuan, G ; Regel, I ; Lian, F ; Friedrich, T ; Hitkova, I ; Hofheinz, R D ; Ströbel, P ; Langer, R ; Keller, G ; Röcken, C ; Zimmermann, W ; Schmid, R M ; Ebert, M P A ; Burgermeister, E

Oncogene, 2013-01, Vol.32 (3), p.375-387 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer

Moehler, M ; Mueller, A ; Hartmann, J.T ; Ebert, M.P ; Al-Batran, S.E ; Reimer, P ; Weihrauch, M ; Lordick, F ; Trarbach, T ; Biesterfeld, S ; Kabisch, M ; Wachtlin, D ; Galle, P.R

European journal of cancer (1990), 2011-07, Vol.47 (10), p.1511-1520 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy
Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy

Kalder, M. ; Kyvernitakis, I. ; Albert, U. S. ; Baier-Ebert, M. ; Hadji, P.

Osteoporosis international, 2015-01, Vol.26 (1), p.353-360 [Periódico revisado por pares]

London: Springer London

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (682)
  2. Revistas revisadas por pares (739)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (810)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1977  (25)
  2. 1977Até1987  (99)
  3. 1988Até1998  (114)
  4. 1999Até2010  (237)
  5. Após 2010  (337)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (772)
  2. Japonês  (137)
  3. Alemão  (38)
  4. Russo  (2)
  5. Francês  (2)
  6. Italiano  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.